Our scientific advances are accelerating the progress of cancer treatment paths…
Every day, we strive to discover and develop pioneering ways to equip physicians with the in-depth data they need and enhance patient’s lives with non-invasive diagnosis methods.
Our technology uses ‘minibody’ antibodies to scan patients head-to-toe, delivering an in-depth visual profile of immunity status, before, during and after treatment.
Using our minibody and cys-diabodies platform technologies we are generating best in class RPT solutions, to kill tumor cells with targeted radiation.
